Form D · Biotechnology

InSitu Biologics, Inc.

Oakdale, MN · CIK 0001723443

Offering snapshot reported Oct 14, 2026 · SEC filing

Reported sold
$1.25M
Offering amount: $3.38M
Investors reported
1
Form D · investor count
Minimum accepted
$2.5M
Reported outside-investor minimum
First sale
Aug 4, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$625K$1.25MAug 10, 2026: $1,250,000.00Aug 10, 2026Oct 14, 2026: $1,250,000.00Oct 14, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 14, 2026Amendment$1,250,000$0vs Aug 10, 20261SEC filing
Aug 10, 2026Initial$1,250,000No comparison1SEC filing
Dec 18, 2025Initial$3,950,000No comparison29SEC filing
Dec 29, 2023Initial$3,000,000No comparison1SEC filing
Feb 25, 2021Initial$4,969,000No comparison22SEC filing
Mar 7, 2018AmendmentYet to sellNo comparison0SEC filing
Dec 7, 2017InitialYet to sellNo comparison0SEC filing
Nov 22, 2017InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Debt, Option to acquire, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-593640
Convertible Promissory Note

Source: Form D, filed Oct 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kevin Barrett Executive
Kevin Bassett Director, Executive
Buzz Benson Director
Mark Ereth Executive
Daniel Halpern Director, Executive
Sandi Klemann Executive
James Knapp Director
Andy La Frence Director
Jim Segermark Executive
Ivan Shaw Director
Bill Taylor Executive
Greg Van Guilder Director
Kay Warnott Executive
Robert Wilson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3510 Hopkins Place N. Building 4
Oakdale, MN, 55128
Phone: 651-337-4799